EPL (500135) Q4 2002 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2002 earnings summary
27 Oct, 2026Executive summary
2002 was the first full-year period for the combined international operations; consolidated revenue reached Rs. 4,949.7 million and net profit Rs. 630.3 million. Prior-period comparisons cover nine months and are not comparable.
Overseas operations contributed 49% of revenue, up from 44% in 2001; global laminated-tube market share rose from 25% to 28%.
Commercial deliveries began from a dedicated US plant supplying Procter & Gamble’s North American requirements; a new China laminator also entered commercial operation.
Financial highlights
Consolidated sales and services were Rs. 4,949.7 million; PBDIT was Rs. 1,522.8 million, PBT before extraordinary items Rs. 866.4 million and net profit Rs. 630.3 million.
Consolidated diluted EPS was Rs. 19.97 and basic EPS Rs. 20.20; consolidated final dividend proposed was Rs. 234.9 million, inclusive of tax.
Indian standalone revenue was Rs. 2,718.0 million; PBDIT Rs. 1,035.8 million, PBT Rs. 665.1 million, PAT Rs. 463.4 million and basic EPS Rs. 14.85.
Extraordinary items of Rs. 34.6 million comprised VRS payments of Rs. 18.6 million, project write-offs of Rs. 8.4 million and net sundry balance write-offs of Rs. 26.2 million.
Raw material consumption was 38.44% of sales versus 40% in the prior period; bad-debt provision was Rs. 1.41 million, with recovery efforts planned for 2003.
Outlook and guidance
Plans include expanding in Eastern Europe, Russia, Africa and Central Asia, while growing customer partnerships and pursuing emerging market segments.
China business restructuring was planned for 2003; Mexican operations were expected to break even in 2003.
The closures joint venture expected to break even and reach full capacity utilisation by year-end 2003, based on orders executed and customer commitments.
Longer-term priorities include turnkey customer solutions, cost-effective product innovation and leadership in packaging for oral care, cosmetics, toiletries and pharmaceuticals.
Latest events from EPL
- Revenue grew 30%, led by B&C, as Europe and cost pressures tempered profit growth.500135
Q2 26/27 - FY98 growth accelerated with expansion, while new capacity and tax disputes shaped risk and returns.500135
Q4 97/98 - Sales and services rose to Rs 152.68 crore as overseas expansion and competition intensified.500135
Q4 96/97 - Steady earnings amid a slowdown, with profitable overseas operations advancing global expansion.500135
Q4 98/99 - Revenue grew 16.2% as global expansion and plastic tubes drove growth amid margin pressure.500135
Q4 2004 - Sales grew 34%, PAT 41%, and global expansion accelerated alongside a Rs. 228 million special dividend.500135
Q4 99/00 - First global consolidation delivered Rs.550 million net profit as acquisition synergies met growth opportunities.500135
Q4 2001 - Revenue rose 12%; EAP and Europe led growth despite pandemic headwinds.500135
Q4 20/21 - Revenue rose 21.5%, while US startup costs restrained profit growth.500135
Q4 2003